{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:15:53Z","timestamp":1773155753614,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.clnu.2008.09.003","type":"journal-article","created":{"date-parts":[[2008,11,30]],"date-time":"2008-11-30T09:16:55Z","timestamp":1228036615000},"page":"34-38","source":"Crossref","is-referenced-by-count":29,"title":["Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin"],"prefix":"10.1016","volume":"28","author":[{"given":"Chun-che","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-chin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.clnu.2008.09.003_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000087267","article-title":"Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan","volume":"49","author":"Lee","year":"2006","journal-title":"Intervirology"},{"key":"10.1016\/j.clnu.2008.09.003_bib2","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S1542-3565(05)00713-5","article-title":"Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy","volume":"3","author":"Omata","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2008.09.003_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00365520600955526","article-title":"Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40kDa) and ribavirin","volume":"42","author":"Foster","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clnu.2008.09.003_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1089-3261(02)00077-6","article-title":"Current therapy for hepatitis C: pegylated interferon and ribavirin","volume":"7","author":"McHutchison","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clnu.2008.09.003_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3350\/kjhep.2008.14.1.36","article-title":"Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C","volume":"14","author":"Kim","year":"2008","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.clnu.2008.09.003_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2893.2003.00482.x","article-title":"Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C","volume":"11","author":"Perrillo","year":"2004","journal-title":"J Viral Hepatol"},{"key":"10.1016\/j.clnu.2008.09.003_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.21565","article-title":"The effects of HCV infection and management on health-related quality of life","volume":"45","author":"Younossi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2008.09.003_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/135965350601100814","article-title":"Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy","volume":"11","author":"Yu","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clnu.2008.09.003_bib9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1478-3231.2006.01354.x","article-title":"Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response","volume":"26","author":"Hung","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2008.09.003_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-4-25","article-title":"Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy","volume":"4","author":"Levent","year":"2006","journal-title":"J Transl Med"},{"key":"10.1016\/j.clnu.2008.09.003_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnu.2008.09.003_bib12","series-title":"Taiwan Nutrient Databases 1998","author":"Department of Health","year":"1998"},{"key":"10.1016\/j.clnu.2008.09.003_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-8981(97)00224-6","article-title":"A routine method for the simultaneous measurement of retinol, \u03b1-tocopherol and five carotenoids in human plasma by reverse phase HPLC","volume":"270","author":"Talwar","year":"1998","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clnu.2008.09.003_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0006-2944(74)90093-3","article-title":"A rapid micromethod for the determination of ascorbic acid in plasma and tissues","volume":"11","author":"Zannoni","year":"1974","journal-title":"Biochem Med"},{"key":"10.1016\/j.clnu.2008.09.003_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-5793(75)80385-1","article-title":"Malignant transformation-linked imbalance: decreased XO activity in hepatomas","volume":"59","author":"Prajda","year":"1975","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clnu.2008.09.003_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0891-5849(96)00377-2","article-title":"The effect of oxygen radical metabolites and vitamin E on glycosylation or proteins","volume":"22","author":"Jain","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clnu.2008.09.003_bib17","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1440-1746.2006.04420.x","article-title":"Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane","volume":"21","author":"Konishi","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2008.09.003_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/clinchem\/46.5.704","article-title":"Vitamin B (1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay","volume":"46","author":"Talwar","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.clnu.2008.09.003_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0378-4347(00)80446-6","article-title":"Determination of the B2 vitamer flavin \u2013 adenine dinucleotide in whole blood by high-performance liquid chromatography with fluorometric detection","volume":"228","author":"Speek","year":"1982","journal-title":"J Chromatogr"},{"key":"10.1016\/j.clnu.2008.09.003_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1570-0232(03)00320-9","article-title":"Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation","volume":"792","author":"Talwar","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed"},{"key":"10.1016\/j.clnu.2008.09.003_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2893.2005.00637.x","article-title":"Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C","volume":"12","author":"Seyam","year":"2005","journal-title":"J Viral Hepatol"},{"key":"10.1016\/j.clnu.2008.09.003_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.hepres.2005.06.008","article-title":"Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C","volume":"33","author":"Watanabe","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clnu.2008.09.003_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jmv.21123","article-title":"Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?","volume":"80","author":"Pellicano","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.clnu.2008.09.003_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2334-5-95","article-title":"Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection","volume":"5","author":"Bolukbas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clnu.2008.09.003_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1152\/ajpgi.00522.2005","article-title":"Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus","volume":"290","author":"Choi","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clnu.2008.09.003_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0006-2952(91)90251-Y","article-title":"Phenolic compounds and an analog as superoxide anion scavengers and antioxidants","volume":"42","author":"Zhou","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clnu.2008.09.003_bib27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/10715760400016162","article-title":"Reactions of arylamine and aminophenol derivatives, and riboflavin with organic radicals","volume":"38","author":"Ksendzova","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.clnu.2008.09.003_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S1368980000000173","article-title":"The role of vitamins in the prevention and control of anaemia","volume":"3","author":"Fishman","year":"2000","journal-title":"Public Health Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561408002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561408002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T21:08:47Z","timestamp":1684703327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561408002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0261561408002021"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2008.09.003","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}